Inspire Medical Systems
INSP
325 hedge funds and large institutions have $6.82B invested in Inspire Medical Systems in 2024 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 122 increasing their positions, 108 reducing their positions, and 55 closing their positions.
23% more capital inflows, than outflows
Capital inflows: $881M | Capital outflows: $718M
13% more repeat investments, than reductions
Existing positions increased: 122 | Existing positions reduced: 108
2.05% more ownership
Funds ownership: 105.25% → 107.3% (+2.1%)
5% less funds holding
Funds holding: 343 → 325 (-18)
20% less call options, than puts
Call options by funds: $130M | Put options by funds: $162M
27% less funds holding in top 10
Funds holding in top 10: 11 → 8 (-3)
27% less first-time investments, than exits
New positions opened: 40 | Existing positions closed: 55
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$231M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$102M |
| 3 |
American Century Companies
Kansas City,
Missouri
|
+$65.7M |
| 4 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$59M |
| 5 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$46.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Slate Path Capital
New York
|
-$59.8M |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$50.4M |
| 3 |
Farallon Capital Management
San Francisco,
California
|
-$44.7M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$41.3M |
| 5 |
Fred Alger Management
New York
|
-$35.9M |
INSP Hedge Fund Activity: Q1 2024 in Review
325 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Inspire Medical Systems (INSP) for Q1 2024, worth a combined $6.82B — up 8% from $6.32B a quarter earlier.
Sellers outnumbered buyers: 55 funds closed out of INSP and 40 opened new positions — a net loss of 15 holders — while 108 trimmed existing stakes and 122 added.
The largest buyer was Fidelity Investments, adding an estimated $231M. The largest seller was Slate Path Capital, exiting entirely with an estimated $59.8M sold.
- 325 institutional investors held Inspire Medical Systems (INSP) as of Q1 2024, down from 343 in Q4 2023.
- Funds reported $6.82B of Inspire Medical Systems stock for Q1 2024, up 8% quarter-over-quarter.
- 40 funds opened new Inspire Medical Systems positions in Q1 2024 and 55 closed out, a net change of -15 holders.
- The largest Inspire Medical Systems buyer in Q1 2024 was Fidelity Investments, an estimated $231M added.
- The largest Inspire Medical Systems seller in Q1 2024 was Slate Path Capital, an estimated $59.8M sold.
Based on aggregated 13F filings for Q1 2024.